“For the first time in over a decade, a striking silence fills the Cheevers' barn-style home,” begins a story in the September issue of the science magazine Discover.
Aug. 23, 2013
|
2 min read
The European Commission has approved the use of the CF therapy Kalydeco™ for people with the G551D mutation ages 6 and older in the European Union.
July 27, 2012
|
1 min read
The European Medicines Agency (EMA) announced today that it has recommended the approval of the CF drug Kalydeco™ for people with the G551D mutation ages 6 and older in the European Union.
May 25, 2012
|
2 min read
Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
Jan. 31, 2012
|
5 min read
Nov. 8, 2011
|
2 min read
Oct. 25, 2011
|
2 min read
May 6, 2011
|
1 min read